Non-profit pharma network ASPET is a 4,000-member scientific society in pharmacology and experimental therapeutics with 51-200 employees and a broad research focus across academia, industry, and government. This presents sales opportunities around member-facing products, conference sponsorships, and society-wide tools or services tailored to research professionals and institutional researchers.

Member-centric platform Recent initiatives include launching ASPET Connect, a member-only online community. This indicates an openness to digital engagement, targeted communications, and subscription-based or premium services that could be partnered with for member outreach, event marketing, and knowledge-sharing tools.

Education and DEI focus ASPET maintains divisions including Pharmacology Education and has invested in DEI initiatives. Opportunities exist for educational platforms, training programs, DEI-focused content, and sponsorships or grants aligned with professional development and inclusive research outreach.

Research and modeling Past work on physiologically-based pharmacokinetic and toxicokinetic modeling suggests openness to advanced research software, data analytics, simulation tools, and collaboration on translational science projects that require modeling, data management, and regulatory-compliant workflows.

Financial scale and partnerships With annual revenue in the mid-range of nonprofit organizations and active engagement within a federated biology community, there are potential partnership opportunities in sponsorship, grant-related services, conference exposure, and technology solutions that support large member organizations and scientific societies.